“Global Autism Spectrum Disorder Market: Growth, Outlook, and Competitive Analysis, 2018 – 2030” is the most recent market study released by Credence Research, Inc. The global autism spectrum disorder market had revenue of about USD 2.1 billion in 2022, and it is predicted that it will increase at a CAGR of more than 7.8% from 2018 to 2030, reaching about USD 3.55 billion.
ASD, or autism spectrum disorder, is a collection of neurological illnesses characterized by chronic difficulties in social interaction and communication and a repetitive/restricted pattern of behavior or activities. The three primary disorders impacting millions worldwide are autistic disorder, Asperger syndrome, and pervasive development disorder (PDD). Autism spectrum disorders market growth is driven by an increase in the prevalence of autism spectrum disorder (ASD) and an increase in the diagnosis rate of autism spectrum disorder (ASD). According to World Health Organization (WHO) research from March 2022, it is anticipated that one in every 100 children worldwide has an autism spectrum disorder. Early diagnosis of ASD is critical for understanding and controlling the disorder. Various studies have found that the typical age of diagnosis ranges between 3 and 6 years, with considerable variances depending on ethnicity and socioeconomic level. Besides, a surge in R&D activities for breakthroughs in autism spectrum disorder therapy, as well as the most recent product launch & product approvals, contributes to the autism spectrum disorders industry growth. Moreover, developments in biotechnology, increased access to healthcare facilities, and growing healthcare expenditure boost the expansion of the global autism spectrum disorders market size. However, a lack of competent experts and social stigma connected with mental health concerns impede the market’s remuneration scope.
Browse the market research report covering the full company profiles, size, trends, strategies @ Autism Spectrum Disorder Market
List of Top Companies Operating in the Autism Spectrum Disorder Market
- Curemark LLC
Curemark LLC is in the biotechnology industry. The company researches, develops, and promotes innovative treatments for neurological disorders such as autism, attention deficit hyperactivity disorder (ADHD), dysautonomia, and Parkinson’s. Curemark provides services to clients in the United States. Curemark’s CM-AT, indicated for ASD in children aged 3 to 8, was granted fast-track designation by the US FDA in May 2022.
- Bristol-Myers Squibb Company
Bristol-Myers Squibb firm (BMS) is a specialist biopharmaceutical firm involved in the discovery, development, licensing, manufacture, marketing, distribution, and sale of medications and related medical goods to patients suffering from serious diseases. Its key areas of interest are cancer, cardiology, immunology, and fibrotic therapeutic programs. The company sells its medicines to wholesalers, retail pharmacies, medical experts, hospitals, and government agencies worldwide. BMS sells its products in the United States, Europe, and Japan. The company researches and develops innovative medications to treat acute diseases in areas with high unmet medical needs. BMS’s headquarters are in New York City, New York, USA.
- Merck & Co. Inc
Merck & Co Inc (Merck) is a biopharmaceutical firm that researches, develops, produces, and markets prescription medications, biologic therapies, vaccines, and animal health products. It provides prescription medications for cardiovascular, cancer, immunological disorders, infectious, respiratory, and women’s diseases, and diabetic therapy. The company sells animal health items such as vaccinations, poultry, cattle, and aquaculture products. Merck offers pharmaceuticals to drug wholesalers, retailers, hospitals, government agencies, managed health care providers, and animal health products to veterinarians, distributors, and livestock producers. The company’s subsidiaries and affiliates operate in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Merck is known as MSD outside of the United States and Canada and is based in Kenilworth, New Jersey.
- Novartis AG
Novartis AG (Novartis) is a pharmaceutical and eye care corporation focusing on discovering, developing, manufacturing, and marketing prescription and generic pharmaceutical products. It sells pharmaceuticals to treat cancer, cardiovascular illness, dermatological issues, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immunological disorders, and infections, among other things. Sandoz is the company’s generic medication and biosimilars division. The Novartis Institutes for BioMedical Research (NIBR) performs research in various disease areas. The corporation has subsidiaries and offices throughout the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Novartis is based in Basel, Switzerland.
- Eli Lilly & Company
Eli Lilly & Company is a pharmaceutical firm that discovers, develops, and markets human healthcare products. The company provides medications for cardiovascular disease, diabetes, endocrinology, cancer, neurological issues, immunological disorders, men’s health, and musculoskeletal issues. Independent wholesale distributors distribute the company’s pharmaceutical health products. Lilly performs research and development to identify and deliver new medications. It also promotes its medications through sales reps and marketing partnerships with other pharmaceutical businesses. North America, South America, Europe, South Asia, the Middle East, Africa, and North Asia-Pacific is also served by the company’s products. Lilly’s headquarters are in Indianapolis, Indiana, in the United States.
- Pfizer Inc
Pfizer Inc (Pfizer) is a pharmaceutical company that discovers, develops, manufactures, and sells biopharmaceuticals. The company’s medications treat cardiovascular, metabolic, and pain illnesses and women’s health, cancer, inflammation, immunological disorders, and uncommon diseases. It also offers sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs), and contract manufacturing services. Pfizer’s goods are distributed by wholesalers, merchants, hospitals, individual provider offices, clinics, government agencies, and pharmacies. It has significant manufacturing operations in India, Japan, Ireland, China, Belgium, Germany, Italy, Singapore, and the United States. The company’s products serve South America, Asia Pacific, North America, Australia, Africa, Europe, and the Middle East. Pfizer’s headquarters are in New York, New York.
- Johnson & Johnson Services Inc
Johnson & Johnson Services Inc is a subsidiary of Johnson & Johnson that manufactures consumer healthcare products. The company’s products are divided into several categories, including consumer health items such as skin health and beauty, essential health products, and MedTech and pharmaceutical products. Johnson & Johnson also sells its products all around the world. The corporation sells its products worldwide under the brand name Johnson & Johnson. Johnson & Johnson’s headquarters are in Brunswick, New Jersey, in the United States.
- Otsuka Pharmaceutical Co. Ltd
Otsuka Pharmaceutical Co. Ltd is a Japanese pharmaceutical firm. The company is dedicated to improving patients’ quality of life by creating breakthrough medications and medical equipment. Otsuka Pharmaceutical Co. Ltd has a strong global presence, with businesses in North America, Europe, and Asia. The company has substantially engaged in research and development to expand its product range in the autism spectrum disorder sector. Otsuka Pharmaceutical Co. Ltd announced the development of Otsuka Digital Health. This digital medicine platform combined sensors and other technology to monitor patients with mental health issues like autism spectrum disorder in 2019.
- Hoffman-La Roche Ltd
F. Hoffmann-La Roche Ltd is a global Swiss healthcare corporation specializing in pharmaceuticals and diagnostics. The company was established in 1896 and is based in Basel, Switzerland. Roche is one of the world’s major pharmaceutical corporations, with a comprehensive product portfolio that includes treatments for cancer, hepatitis, multiple sclerosis, and other ailments. The company extensively invests in R&D and is a pioneer in personalized healthcare, which entails designing therapies based on a patient’s unique genetic profile. Roche has also recently increased its focus on digital health solutions, acquiring many businesses in this field. Roche operates in over 100 countries and employs about 100,000 people globally.